Literature DB >> 19812270

Acquisition of high-level mupirocin resistance and its fitness cost among methicillin-resistant Staphylococcus aureus strains with low-level mupirocin resistance.

Kanokporn Mongkolrattanothai1, Lisa Pumfrey, Peggy Mankin, Barry M Gray.   

Abstract

We investigated whether methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) isolates with low-level mupirocin resistance can serve as recipients of a pSK41-like plasmid conferring high-level mupirocin resistance without substantial fitness cost. Our results suggest that acquisition of the plasmid conferring high-level mupirocin resistance was not necessarily associated with fitness cost in some MRSA recipients with low-level mupirocin resistance.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19812270      PMCID： PMC2786619          DOI： 10.1128/JCM.01022-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  23 in total

1.  Nasal mupirocin treatment of pharynx-colonized methicillin resistant Staphylococcus aureus: preliminary study with 10 carrier infants.

Authors:  T Hayakawa; T Hayashidera; S Katsura; K Yoneda; T Kusunoki
Journal:  Pediatr Int       Date:  2000-02       Impact factor: 1.524

2.  Survey of high- and low-level mupirocin-resistant strains of methicillin-resistant Staphylococcus aureus in 15 Japanese hospitals.

Authors:  Shigeru Fujimura; Akira Watanabe
Journal:  Chemotherapy       Date:  2003-05       Impact factor: 2.544

3.  Mutations affecting the Rossman fold of isoleucyl-tRNA synthetase are correlated with low-level mupirocin resistance in Staphylococcus aureus.

Authors:  Martin Antonio; Neil McFerran; Mark J Pallen
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

4.  Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus.

Authors:  H Watanabe; H Masaki; N Asoh; K Watanabe; K Oishi; S Kobayashi; A Sato; R Sugita; T Nagatake
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

5.  Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Eileen Ingham; Colin Fishwick; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

6.  Co-transfer of plasmids in association with conjugative transfer of mupirocin or mupirocin and penicillin resistance in methicillin-resistant Staphylococcus aureus.

Authors:  A Pawa; W C Noble; S A Howell
Journal:  J Med Microbiol       Date:  2000-12       Impact factor: 2.472

7.  The isoleucyl-tRNA synthetase mutation V588F conferring mupirocin resistance in glycopeptide-intermediate Staphylococcus aureus is not associated with a significant fitness burden.

Authors:  Julian G Hurdle; Alex J O'Neill; Ian Chopra
Journal:  J Antimicrob Chemother       Date:  2003-12-04       Impact factor: 5.790

8.  On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus.

Authors:  J Hughes; G Mellows
Journal:  J Antibiot (Tokyo)       Date:  1978-04       Impact factor: 2.649

9.  Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001.

Authors:  Michael Kresken; Dieter Hafner; Franz-Josef Schmitz; Thomas A Wichelhaus
Journal:  Int J Antimicrob Agents       Date:  2004-06       Impact factor: 5.283

Review 10.  Intestinal carriage of Staphylococcus aureus: how does its frequency compare with that of nasal carriage and what is its clinical impact?

Authors:  D S Acton; M J Tempelmans Plat-Sinnige; W van Wamel; N de Groot; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-08       Impact factor: 3.267
View more
  2 in total

1.  Mupirocin-induced mutations in ileS in various genetic backgrounds of methicillin-resistant Staphylococcus aureus.

Authors:  Andie S Lee; Yann Gizard; Joanna Empel; Eve-Julie Bonetti; Stephan Harbarth; Patrice François
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

2.  Testing the role of genetic background in parallel evolution using the comparative experimental evolution of antibiotic resistance.

Authors:  Tom Vogwill; Mila Kojadinovic; Victoria Furió; R Craig MacLean
Journal:  Mol Biol Evol       Date:  2014-09-16       Impact factor: 16.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.